Investing Profile

Martijn Kleijwegt

VCInvestor
Partner at EQT Life Sciences
eqtgroup.com/about/people/mar...Amsterdam, Netherlands
Photo of Martijn Kleijwegt, Partner at EQT Life Sciences
Your Intro Paths to Martijn Kleijwegt

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Martijn Kleijwegt on

cb
Current Investing Position
EQT Life Sciences Partner
Investment Range
$11.0M - $65.0M
Sweet Spot
$25.0M
Investments On Record
9
Current Fund Size
€260M

Martijn Kleijwegt is on these Sector & Stage Rankings

Martijn Kleijwegt's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
PanTera
Series ASep 2024$110M
$110M
Vico Therapeutics
Series BJan 2024$72M
Series AJul 2020$31M
$120M
Co-investors: Amy Schulman (Polaris Partners), Felice Verduyn - van Weegen (EQT Life Sciences), Rémi Droller (Kurma Partners), Silvia Noiman (Pontifax Venture Capital), Jean-François Rivassou (Kurma Partners)
AM Pharma
Series FJul 2019$130M
$210M
Co-investors: Raphael Wisniewski (Andera Partners), Geert-Jan Mulder (Forbion), Rémi Droller (Kurma Partners), Joël Jean-Mairet (Ysios Capital), Felice Verduyn - van Weegen (EQT Life Sciences), Laia Crespo (Sanofi Ventures)
Eloxx
Series CAug 2017$8M
$38M
Co-investors: Janice Bourque (Hercules Capital)
Orphazyme
Series UnknownMar 2017$15M
$15M
Prosensa
Series UnknownJan 2012$30M
Series AFeb 2007$18M
$48M
Co-investors: David Mott (Mott Family Capital)
ActoGeniX
Series UnknownSep 2006$25M
$25M